Why the study?
Does the presence of prior vascular disease affect compliance with evidence-based quality-of-care treatments and in-hospital mortality in patients presenting with acute coronary syndrome?
Observational (n=143,999)
Yes
Does the presence of prior vascular disease affect compliance with evidence-based quality-of-care treatments and in-hospital mortality in patients presenting with acute coronary syndrome?
Patients with acute coronary syndrome and prior atherosclerosis have higher in-hospital mortality but paradoxically receive fewer evidence-based secondary prevention treatments, highlighting a critical gap in quality of care.
Answers are grounded in this paper and cite their sources.
Signals quality-of-care gap in ACS with prior atherosclerosis; hypothesis-generating and requires prospective confirmation before guiding practice.
BACKGROUND: Patients with prior atherosclerosis in 1 or more vascular territories (coronary, cerebrovascular, or peripheral arterial) who present with acute coronary syndromes have high cardiovascular risk and may benefit significantly from evidence-based therapies, yet whether these are used consistently is unknown. METHODS AND RESULTS: The Get With the Guidelines-Coronary Artery Disease database was queried to determine whether compliance with quality-of-care treatments for acute coronary syndrome patients was associated with the extent of prior vascular disease. A total of 143 999 patients enrolled at 438 sites between January 2000 and January 2008 were classified according to the absence (n=98 136; 68%) or presence of known preexistent atherosclerosis (before admission) in 1, 2, or 3 vascular territories (n=37 633 [26%], n=7369 [5%], and n=861 [0.6%], respectively). Overall in-hospital mortality was 5.3%, and mean length of stay was 5.6+/-6.7 days. Compared with patients without prior vascular disease, patients with prior vascular disease were older and had more comorbidities. They were less likely to undergo coronary revascularization and had longer duration of hospital stay and higher in-hospital mortality. After adjustment for clinical and hospital characteristics, compared with patients without prior vascular disease, patients with prior vascular disease had higher mortality and were less likely to receive 3 particular treatments (lipid-lowering therapy, smoking cessation counseling, and angiotensin-converting enzyme inhibitor for left ventricular dysfunction). CONCLUSIONS: Compared with acute coronary syndrome patients without prior vascular disease, those with prior atherosclerosis had higher in-hospital mortality yet were paradoxically less likely to receive specific evidence-based acute coronary syndrome treatments, which can form the basis for targeted intervention.
No takes yet. Share an insight, caveat, or question.
Brilakis et al. (2009) conducted an observational in Acute Coronary Syndrome (n=143,999). Prior atherosclerosis in 1 or more vascular territories vs. Absence of prior vascular disease was evaluated on Compliance with quality-of-care treatments and in-hospital mortality.
Synapse has enriched 10 related papers. Consider them for comparative context: